AMIC: Reduced DEXA payments may curb screening, up fracture incidence

The Access to Medical Imaging Coalition (AMIC) is urging the Medicare Payment Advisory Commission (MedPAC) to consider the correlation between Medicare reimbursement and patient outcomes as it advises Congress about physician payments. 

In a letter to MedPAC, AMIC highlighted a study on dual energy x-ray absorptiometry (DEXA) screenings for osteoporosis that illustrates the correlation between inadequate Medicare reimbursement and adverse patient outcomes.

The study, published in the December 2011 issue of Health Affairs, found that DEXA testing in all Medicare Part B settings plateaued in 2007-2009 after the Deficit Reduction Act of 2005 and regulations cut Part B imaging payments, following a decade of growth in the use of DEXA to detect osteoporosis. According to the study, in those years, 800,000 fewer tests than expected were performed for Medicare beneficiaries—tests that might have prevented 12,000 fractures and their associated healthcare costs, the AMIC stated.

“Bottom line, had the rates not been cut, we would not have seen that devastating number of fractures,” said Donna Fiorentino, co-author of the Health Affairs study, in a statement issued by AMIC.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.